ACRS
Aclaris TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ACRS vs peer average
49/100
ACRS vs. peer average (C vs. C)
Grade spread
A 2 · B 3 · C 1 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CLYM is the first available peer comparator.
A closer small-cap clinical-stage biotech comparator on event and financing sensitivity, though not a close mechanism match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACRS
Aclaris Therapeutics
CLYM
Climb Bio
Grade
C
D
Momentum
91
95
Value
41
41
Sentiment
27
17
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs CLYM
ACRS / CLYM
Grade Position
In line
ACRS vs. peer average (C vs. C)
49/100
Momentum
91
CLYMValue
41
ACRSSentiment
27
ACRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACRS
CLYM is the first peer returned for this comparison set.